Libin Zou

Shanghai, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 9 publications

Lactobacillus plantarum-derived indole-3-lactic acid inhibits prostate cancer progression through ASF1B/ENO1 axis and remodels the tumor microenvironment to enhance anti-PD-1 therapy.

Lactobacillus plantarum-derived indole-3-lactic acid inhibits prostate cancer progression through ASF1B/ENO1 axis and remodels the tumor microenvironment to enhance anti-PD-1 therapy.

Journal: Molecular biomedicine

Published: November 10, 2025

USP21/YBX1/HIF1-α promotes the progression of prostate cancer.

USP21/YBX1/HIF1-α promotes the progression of prostate cancer.

Journal: Journal of translational medicine

Published: July 21, 2025

Correction: Gut microbiota, metabolites, and cytokines in relation to the risk of prostate cancer in the Asian population.

Correction: Gut microbiota, metabolites, and cytokines in relation to the risk of prostate cancer in the Asian population.

Journal: Frontiers in oncology

Published: June 14, 2025

NUF2 activated by YY1 promotes prostate cancer malignancy via p38/MAPK signaling axis and serves as a therapeutic target.

NUF2 activated by YY1 promotes prostate cancer malignancy via p38/MAPK signaling axis and serves as a therapeutic target.

Journal: Biochemical pharmacology

Published: December 09, 2024

The role and mechanism of NAT10-mediated ac4C modification in tumor development and progression.

The role and mechanism of NAT10-mediated ac4C modification in tumor development and progression.

Journal: MedComm

Published: July 19, 2024

Gut microbiota, metabolites, and cytokines in relation to the risk of prostate cancer in the Asian population.

Gut microbiota, metabolites, and cytokines in relation to the risk of prostate cancer in the Asian population.

Journal: Frontiers in oncology

Published: July 17, 2024

Acetyltransferase NAT10 promotes an immunosuppressive microenvironment by modulating CD8+ T cell activity in prostate cancer.

Acetyltransferase NAT10 promotes an immunosuppressive microenvironment by modulating CD8+ T cell activity in prostate cancer.

Journal: Molecular biomedicine

Published: April 26, 2024

CircCNOT6L modulates alternative splicing of SLC7A11 via splicing factor SRSF2 to confer ferroptosis resistance and promote metastasis in prostate cancer.

CircCNOT6L modulates alternative splicing of SLC7A11 via splicing factor SRSF2 to confer ferroptosis resistance and promote metastasis in prostate cancer.

Journal: Experimental & molecular medicine

Published: February 19, 2024

The functions and mechanisms of RNA modification in prostate: Current status and future perspectives.

The functions and mechanisms of RNA modification in prostate: Current status and future perspectives.

Journal: Frontiers in genetics

Published: February 02, 2024

Showing 1-9 of 9

Last Updated: 09/26/2026